Extrawell Pharmaceutical Holdings Limited (00858) Extends Long Stop Date and Delays Major Transaction Circular

Bulletin Express

Feb 27

Extrawell Pharmaceutical Holdings Limited (the “Company”) (Stock Code: 00858) announced an extension of the long stop date related to the proposed fourth amendments to the terms and conditions of its bonds. According to the fourth amendment deed, if conditions were not met by 31 March 2026, the deed would lapse automatically. An extension letter dated 27 February 2026 now pushes the deadline to 30 June 2026, or another date mutually agreed by the parties. Other terms and conditions of the deed remain unchanged.

The Company also announced a delay in dispatching the circular for the major transaction linked to the same amendments. Originally set for on or before 6 March 2026, the dispatch date is now expected to be on or before 30 May 2026, to allow additional time for finalizing the required information.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1162947299"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1162947299\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1162947299?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-27 22:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162947299","market":"hk","top_or_hot":-1,"title":"Extrawell Pharmaceutical Holdings Limited (00858) Extends Long Stop Date and Delays Major Transaction Circular","media":"Bulletin Express","content":"<p>Extrawell Pharmaceutical Holdings Limited (the “Company”) (Stock Code: 00858) announced an extension of the long stop date related to the proposed fourth amendments to the terms and conditions of its bonds. According to the fourth amendment deed, if conditions were not met by 31 March 2026, the deed would lapse automatically. An extension letter dated 27 February 2026 now pushes the deadline to 30 June 2026, or another date mutually agreed by the parties. Other terms and conditions of the deed remain unchanged.</p>\n<p>The Company also announced a delay in dispatching the circular for the major transaction linked to the same amendments. Originally set for on or before 6 March 2026, the dispatch date is now expected to be on or before 30 May 2026, to allow additional time for finalizing the required information.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Extrawell Pharmaceutical Holdings Limited (00858) Extends Long Stop Date and Delays Major Transaction Circular</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nExtrawell Pharmaceutical Holdings Limited (00858) Extends Long Stop Date and Delays Major Transaction Circular\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-27 22:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Extrawell Pharmaceutical Holdings Limited (the “Company”) (Stock Code: 00858) announced an extension of the long stop date related to the proposed fourth amendments to the terms and conditions of its bonds. According to the fourth amendment deed, if conditions were not met by 31 March 2026, the deed would lapse automatically. An extension letter dated 27 February 2026 now pushes the deadline to 30 June 2026, or another date mutually agreed by the parties. Other terms and conditions of the deed remain unchanged.</p>\n<p>The Company also announced a delay in dispatching the circular for the major transaction linked to the same amendments. Originally set for on or before 6 March 2026, the dispatch date is now expected to be on or before 30 May 2026, to allow additional time for finalizing the required information.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00858","symbol_name":"精优药业","start_time":0,"source_url":"","article_id":"1162947299","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162947299","pubTimestamp":1772202152,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Extrawell Pharmaceutical Holdings Limited (the “Company”) (Stock Code: 00858) announced an extension of the long stop date related to the proposed fourth amendments to the terms and conditions of its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00858":"精优药业"},"translate_title":"Extrawell Pharmaceutical Holdings Limited(00858)延长最后截止日期及延迟主要交易通函","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00858":1},"content_text":"Extrawell Pharmaceutical Holdings Limited (the “Company”) (Stock Code: 00858) announced an extension of the long stop date related to the proposed fourth amendments to the terms and conditions of its bonds. According to the fourth amendment deed, if conditions were not met by 31 March 2026, the deed would lapse automatically. An extension letter dated 27 February 2026 now pushes the deadline to 30 June 2026, or another date mutually agreed by the parties. Other terms and conditions of the deed remain unchanged.\nThe Company also announced a delay in dispatching the circular for the major transaction linked to the same amendments. Originally set for on or before 6 March 2026, the dispatch date is now expected to be on or before 30 May 2026, to allow additional time for finalizing the required information.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}